Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Structural biology of CRISPR–Cas immunity and genome editing enzymes

Wang, Joy Y., Pausch, Patrick, Doudna, Jennifer A. · 2022 · Nature Reviews Microbiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41579-022-00739-4

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 162

  1. Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007). · DOI · Paper page
  2. Hille, F. et al. The biology of CRISPR-Cas: backward and forward. Cell 172, 1239–1259 (2018). · DOI · Paper page
  3. Shmakov, S. et al. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 60, 385–397 (2015). · DOI · Paper page
  4. Grissa, I., Vergnaud, G. & Pourcel, C. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8, 172 (2007). · DOI · Paper page
  5. McGinn, J. & Marraffini, L. A. Molecular mechanisms of CRISPR–Cas spacer acquisition. Nat. Rev. Microbiol. 17, 7–12 (2019). · DOI · Paper page
  6. Gleditzsch, D. et al. PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures. RNA Biol. 16, 504–517 (2019). · DOI · Paper page
  7. Behler, J. & Hess, W. R. Approaches to study CRISPR RNA biogenesis and the key players involved. Methods 172, 12–26 (2020). · DOI
  8. Marino, N. D., Pinilla-Redondo, R., Csörgő, B. & Bondy-Denomy, J. Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies. Nat. Methods 17, 471–479 (2020). · DOI · Paper page
  9. Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2019). · DOI · Paper page
  10. Jia, N. & Patel, D. J. Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins. Nat. Rev. Mol. Cell Biol. 22, 563–579 (2021). · DOI
  11. Liu, T. Y. & Doudna, J. A. Chemistry of class 1 CRISPR-Cas effectors: binding, editing, and regulation. J. Biol. Chem. 295, 14473–14487 (2020). · DOI
  12. Taylor, H. N. et al. Positioning diverse type IV structures and functions within class 1 CRISPR-Cas systems. Front. Microbiol. 12, 674522 (2021). · DOI
  13. O’Connell, M. R. Molecular mechanisms of RNA targeting by Cas13-containing type VI CRISPR–Cas systems. J. Mol. Biol. 431, 66–87 (2019). · DOI · Paper page
  14. Krupovic, M., Makarova, K. S., Forterre, P., Prangishvili, D. & Koonin, E. V. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity. BMC Biol. 12, 36 (2014). · DOI · Paper page
  15. Hickman, A. B., Kailasan, S., Genzor, P., Haase, A. D. & Dyda, F. Casposase structure and the mechanistic link between DNA transposition and spacer acquisition by CRISPR-Cas. eLife 9, e50004 (2020). This work describes the structure of the casposase and its site specificity, providing insight into the evolutionary origins of the Cas1 protein. · DOI
  16. Wang, J. et al. Structural and mechanistic basis of PAM-dependent spacer acquisition in CRISPR-Cas systems. Cell 163, 840–853 (2015). · DOI · Paper page
  17. Nuñez, J. K., Harrington, L. B., Kranzusch, P. J., Engelman, A. N. & Doudna, J. A. Foreign DNA capture during CRISPR–Cas adaptive immunity. Nature 527, 535–538 (2015). · DOI · Paper page
  18. Xiao, Y., Ng, S., Nam, K. H. & Ke, A. How type II CRISPR–Cas establish immunity through Cas1–Cas2-mediated spacer integration. Nature 550, 137–141 (2017). · DOI
  19. Wright, A. V. et al. Structures of the CRISPR genome integration complex. Science 357, 1113–1118 (2017). · DOI
  20. Hickman, A. B. & Dyda, F. DNA transposition at work. Chem. Rev. 116, 12758–12784 (2016). · DOI
  21. Béguin, P., Charpin, N., Koonin, E. V., Forterre, P. & Krupovic, M. Casposon integration shows strong target site preference and recapitulates protospacer integration by CRISPR-Cas systems. Nucleic Acids Res. 44, 10367–10376 (2016).
  22. Yosef, I., Goren, M. G. & Qimron, U. Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40, 5569–5576 (2012). · DOI · Paper page
  23. Datsenko, K. A. et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 3, 945 (2012). · DOI · Paper page
  24. Arslan, Z., Hermanns, V., Wurm, R., Wagner, R. & Pul, Ü. Detection and characterization of spacer integration intermediates in type IE CRISPR–Cas system. Nucleic Acids Res. 42, 7884–7893 (2014). · DOI
  25. Nuñez, J. K., Lee, A. S. Y., Engelman, A. & Doudna, J. A. Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity. Nature 519, 193–198 (2015). · DOI · Paper page
  26. Rollie, C., Schneider, S., Brinkmann, A. S., Bolt, E. L. & White, M. F. Intrinsic sequence specificity of the Cas1 integrase directs new spacer acquisition. eLife 4, e08716 (2015). · DOI
  27. Wright, A. V. & Doudna, J. A. Protecting genome integrity during CRISPR immune adaptation. Nat. Struct. Mol. Biol. 23, 876–883 (2016). · DOI
  28. Nuñez, J. K. et al. Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity. Nat. Struct. Mol. Biol. 21, 528–534 (2014). · DOI · Paper page
  29. Sasnauskas, G. & Siksnys, V. CRISPR adaptation from a structural perspective. Curr. Opin. Struct. Biol. 65, 17–25 (2020). · DOI
  30. Wilkinson, M. et al. Structure of the DNA-bound spacer Capture complex of a type II CRISPR-Cas system. Mol. Cell 75, 90–101.e5 (2019). · DOI
  31. Hu, C. et al. Mechanism for Cas4-assisted directional spacer acquisition in CRISPR–Cas. Nature 598, 515–520 (2021). This work provides the mechanism and structural basis for Cas4-assisted PAM processing and describes a model in which PAM sequestration and delayed processing influences the orientation of spacer integration. · DOI
  32. Burstein, D. et al. New CRISPR–Cas systems from uncultivated microbes. Nature 542, 237–241 (2016). · DOI · Paper page
  33. Makarova, K. S., Wolf, Y. I. & Koonin, E. V. Classification and nomenclature of CRISPR-Cas systems: where from here? CRISPR J. 1, 325–336 (2018). · DOI · Paper page
  34. Wright, A. V. et al. A functional mini-integrase in a two-protein type V-C CRISPR system. Mol. Cell 73, 727–737 (2019). This work describes a tetrameric CRISPR integrase that may represent the ancestral CRISPR integrase. · DOI
  35. Santiago-Frangos, A., Buyukyoruk, M., Wiegand, T., Krishna, P. & Wiedenheft, B. Distribution and phasing of sequence motifs that facilitate CRISPR adaptation. Curr. Biol. 31, 3515–3524 (2021). · DOI
  36. Koonin, E. V. & Makarova, K. S. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes. RNA Biol. 10, 679–686 (2013). · DOI · Paper page
  37. Bertelsen, M. B. et al. Structural basis for toxin inhibition in the VapXD toxin-antitoxin system. Structure 29, 139–150 (2021). · DOI
  38. Kwon, A.-R. et al. Structural and biochemical characterization of HP0315 from Helicobacter pylori as a VapD protein with an endoribonuclease activity. Nucleic Acids Res. 40, 4216–4228 (2012). · DOI
  39. Ka, D., Kim, D., Baek, G. & Bae, E. Structural and functional characterization of Streptococcus pyogenes Cas2 protein under different pH conditions. Biochem. Biophys. Res. Commun. 451, 152–157 (2014). · DOI
  40. Silas, S. et al. Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein. Science 351, aad4234 (2016). · DOI · Paper page
  41. Koonin, E. V. & Makarova, K. S. Mobile genetic elements and evolution of CRISPR-Cas systems: all the way there and back. Genome Biol. Evol. 9, 2812–2825 (2017). · DOI · Paper page
  42. Silas, S. et al. On the origin of reverse transcriptase-using CRISPR-Cas systems and their hyperdiverse, enigmatic spacer repertoires. mBio 8, e00897-17 (2017). · DOI · Paper page
  43. Mohr, G. et al. A reverse transcriptase-Cas1 fusion protein contains a Cas6 domain required for both CRISPR RNA biogenesis and RNA spacer acquisition. Mol. Cell 72, 700–714 (2018). · DOI
  44. Wang, J. Y. et al. Structural coordination between active sites of a CRISPR reverse transcriptase-integrase complex. Nat. Commun. 12, 2571 (2021). This work describes the structure of a Cas6–RT–Cas1–Cas2 complex, highlighting interactions between the three domains and the potential functional implications for CRISPR adaptation. · DOI
  45. Stamos, J. L., Lentzsch, A. M. & Lambowitz, A. M. Structure of a thermostable group II intron reverse transcriptase with template-primer and its functional and evolutionary implications. Mol. Cell 68, 926–939 (2017). · DOI
  46. Nussenzweig, P. M. & Marraffini, L. A. Molecular mechanisms of CRISPR-Cas immunity in bacteria. Annu. Rev. Genet. 54, 93–120 (2020). · DOI · Paper page
  47. Levy, A. et al. CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature 520, 505–510 (2015). · DOI · Paper page
  48. Wigley, D. B. Bacterial DNA repair: recent insights into the mechanism of RecBCD, AddAB and AdnAB. Nat. Rev. Microbiol. 11, 9–13 (2013). · DOI · Paper page
  49. Kim, S. et al. Selective loading and processing of prespacers for precise CRISPR adaptation. Nature 579, 141–145 (2020). This work describes how the kinetic coordination of prespacer processing and PAM trimming affects the orientation of spacer integration and presents a model for prespacer selection and processing. · DOI
  50. Ramachandran, A., Summerville, L., Learn, B. A., DeBell, L. & Bailey, S. Processing and integration of functionally oriented prespacers in the Escherichia coli CRISPR system depends on bacterial host exonucleases. J. Biol. Chem. 295, 3403–3414 (2020). · DOI
  51. Kieper, S. N. et al. Cas4 facilitates PAM-compatible spacer selection during CRISPR adaptation. Cell Rep. 22, 3377–3384 (2018). · DOI
  52. Lee, H., Dhingra, Y. & Sashital, D. G. The Cas4-Cas1-Cas2 complex mediates precise prespacer processing during CRISPR adaptation. eLife 8, e44248 (2019). · DOI
  53. Musharova, O. et al. Prespacers formed during primed adaptation associate with the Cas1–Cas2 adaptation complex and the Cas3 interference nuclease–helicase. Proc. Natl Acad. Sci. USA 118, e2021291118 (2021). · doi:10.1073/pnas.2021291118
  54. Wu, C. et al. Mechanisms of spacer acquisition by sequential assembly of the adaptation module in Synechocystis. Nucleic Acids Res. 49, 2973–2984 (2021). · DOI
  55. Drabavicius, G. et al. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system. EMBO Rep. 19, e45543 (2018). · DOI
  56. Lee, H., Zhou, Y., Taylor, D. W. & Sashital, D. G. Cas4-dependent prespacer processing ensures high-fidelity programming of CRISPR arrays. Mol. Cell 70, 48–59.e5 (2018). · DOI
  57. Heler, R. et al. Cas9 specifies functional viral targets during CRISPR–Cas adaptation. Nature 519, 199–202 (2015). · DOI · Paper page
  58. Heler, R. et al. Mutations in Cas9 enhance the rate of acquisition of viral spacer sequences during the CRISPR-Cas immune response. Mol. Cell 65, 168–175 (2017). · DOI
  59. Jakhanwal, S. et al. A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration. Nucleic Acids Res. 49, 3546–3556 (2021).
  60. Swarts, D. C., Mosterd, C., van Passel, M. W. J. & Brouns, S. J. J. CRISPR interference directs strand specific spacer acquisition. PLoS ONE 7, e35888 (2012). · DOI · Paper page
  61. Dillard, K. E. et al. Assembly and translocation of a CRISPR-Cas primed acquisition complex. Cell 175, 934–946.e15 (2018). · DOI
  62. Xue, C., Whitis, N. R. & Sashital, D. G. Conformational control of Cascade interference and priming activities in CRISPR immunity. Mol. Cell 64, 826–834 (2016). · DOI
  63. Nicholson, T. J. et al. Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems. RNA Biol. 16, 566–576 (2019). · DOI
  64. Nussenzweig, P. M., McGinn, J. & Marraffini, L. A. Cas9 cleavage of viral genomes primes the acquisition of new immunological memories. Cell Host Microbe 26, 515–526.e6 (2019). · DOI
  65. Shipman, S. L., Nivala, J., Macklis, J. D. & Church, G. M. Molecular recordings by directed CRISPR spacer acquisition. Science 353, aaf1175 (2016). · DOI · Paper page
  66. Sheth, R. U., Yim, S. S., Wu, F. L. & Wang, H. H. Multiplex recording of cellular events over time on CRISPR biological tape. Science 358, 1457–1461 (2017). · DOI · Paper page
  67. Schmidt, F., Cherepkova, M. Y. & Platt, R. J. Transcriptional recording by CRISPR spacer acquisition from RNA. Nature 562, 380–385 (2018). · DOI
  68. Munck, C., Sheth, R. U., Freedberg, D. E. & Wang, H. H. Recording mobile DNA in the gut microbiota using an Escherichia coli CRISPR-Cas spacer acquisition platform. Nat. Commun. 11, 95 (2020). · DOI
  69. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012). · DOI · Paper page
  70. Gasiunas, G. & Barrangou, R. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl Acad. Sci. USA 109, E2579–E2586 (2012). · DOI · Paper page
  71. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013). · DOI · Paper page
  72. Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013). · DOI · Paper page
  73. Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015). · DOI · Paper page
  74. Liu, J.-J. et al. CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature 566, 218–223 (2019). · DOI · Paper page
  75. Strecker, J. et al. Engineering of CRISPR-Cas12b for human genome editing. Nat. Commun. 10, 212 (2019). · DOI · Paper page
  76. Pausch, P. et al. CRISPR-CasΦ from huge phages is a hypercompact genome editor. Science 369, 333–337 (2020). · DOI · Paper page
  77. Swarts, D. C. & Jinek, M. Cas9 versus Cas12a/Cpf1: structure-function comparisons and implications for genome editing. Wiley Interdiscip. Rev. RNA 9, e1481 (2018). · DOI · Paper page
  78. Stella, S., Alcón, P. & Montoya, G. Class 2 CRISPR–Cas RNA-guided endonucleases: Swiss Army knives of genome editing. Nat. Struct. Mol. Biol. 24, 882–892 (2017). · DOI
  79. Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J. A. A Cas9–guide RNA complex preorganized for target DNA recognition. Science 348, 1477–1481 (2015). · DOI · Paper page
  80. Anders, C., Niewoehner, O., Duerst, A. & Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569–573 (2014). · DOI · Paper page
  81. Jiang, F. et al. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science 351, 867–871 (2016). · DOI · Paper page
  82. Sternberg, S. H., LaFrance, B., Kaplan, M. & Doudna, J. A. Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527, 110–113 (2015). · DOI · Paper page
  83. Zhang, Y. et al. Catalytic-state structure and engineering of Streptococcus thermophilus Cas9. Nat. Catal. 3, 813–823 (2020). · DOI
  84. Sun, W. et al. Structures of Neisseria meningitidis Cas9 complexes in catalytically poised and anti-CRISPR-inhibited states. Mol. Cell 76, 938–952.e5 (2019). · DOI
  85. Pacesa, M. & Jinek, M. Mechanism of R-loop formation and conformational activation of Cas9. Preprint at bioRxiv https://doi.org/10.1101/2021.09.16.460614 (2021). · DOI
  86. Bravo, J. P. K. et al. Structural basis for mismatch surveillance by CRISPR-Cas9. Nature 603, 343–347 (2022). This study demonstrates how excessive target mismatches inhibit DNA cutting by Cas9 and reveals a most comprehensive structure of Cas9 bound to the DNA cleavage product. · DOI · Paper page
  87. Zhu, X. et al. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9. Nat. Struct. Mol. Biol. 26, 679–685 (2019). · DOI · Paper page
  88. Palermo, G. et al. Protospacer adjacent motif-induced allostery activates CRISPR-Cas9. J. Am. Chem. Soc. 139, 16028–16031 (2017). · DOI
  89. Nierzwicki, L. et al. Enhanced specificity mutations perturb allosteric signaling in CRISPR-Cas9. eLife 10, e73601 (2021). · DOI
  90. Zuo, Z. et al. Structural and functional insights into the bona fide catalytic state of Streptococcus pyogenes Cas9 HNH nuclease domain. eLife 8, e46500 (2019). · DOI
  91. Belato, H. B. et al. Structural and dynamic insights into the HNH nuclease of divergent Cas9 species. J. Struct. Biol. 214, 107814 (2021). · DOI
  92. Globyte, V., Lee, S. H., Bae, T., Kim, J. & Joo, C. CRISPR /Cas9 searches for a protospacer adjacent motif by lateral diffusion. EMBO J. 38, e99466 (2019). · DOI
  93. Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62–67 (2014). · DOI · Paper page
  94. Cofsky, J. C., Soczek, K. M., Knott, G. J., Nogales, E. & Doudna, J. A. CRISPR-Cas9 bends and twists DNA to read its sequence. Nat. Struct. Mol. Biol. 29, 395–402 (2022). This article for the first time reveals structural insights into how Cas9 opens dsDNA to interrogate target sequences. · DOI
  95. Ivanov, I. E. et al. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling. Proc. Natl Acad. Sci. USA 117, 5853–5860 (2020). · DOI
  96. Liu, M.-S. et al. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA. Nat. Commun. 11, 3576 (2020). · DOI
  97. Yamano, T. et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949–962 (2016). This study reveals for the first time how Cas12a recognizes DNA. · DOI · Paper page
  98. Dong, D. et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532, 522–526 (2016). · DOI · Paper page
  99. Pausch, P. et al. DNA interference states of the hypercompact CRISPR-CasΦ effector. Nat. Struct. Mol. Biol. 28, 652–661 (2021). This article describes how a minimal Cas12 enzyme binds dsDNA and catalyses DNA cleavage. · DOI
  100. Carabias, A. et al. Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3. Nat. Commun. 12, 4476 (2021). · DOI
  101. Yang, H., Gao, P., Rajashankar, K. R. & Patel, D. J. PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell 167, 1814–1828 (2016). · DOI · Paper page
  102. Tsuchida, C. A. et al. Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity. Mol. Cell 82, 1199–1209.e6 (2022). · DOI
  103. Harrington, L. B. et al. A scoutRNA is required for some type V CRISPR-Cas systems. Mol. Cell 79, 416–424.e5 (2020). · DOI
  104. Huang, C. J., Adler, B. A. & Doudna, J. A. A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression. Preprint at bioRxiv https://doi.org/10.1101/2021.12.06.471469 (2021). · doi:10.1101/2021.12.06.471469
  105. Kurihara, N. et al. Structure of the type V-C CRISPR-Cas effector enzyme. Mol. Cell 82, 1–13 (2022). · DOI
  106. Harrington, L. B. et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362, 839–842 (2018). · DOI · Paper page
  107. Takeda, S. N. et al. Structure of the miniature type V-F CRISPR-Cas effector enzyme. Mol. Cell 81, 558–570 (2021). · DOI · Paper page
  108. Xiao, R., Li, Z., Wang, S., Han, R. & Chang, L. Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR–Cas12f nuclease. Nucleic Acids Res. 49, 4120–4128 (2021). · DOI
  109. Li, Z., Zhang, H., Xiao, R., Han, R. & Chang, L. Cryo-EM structure of the RNA-guided ribonuclease Cas12g. Nat. Chem. Biol. 17, 387–393 (2021). · DOI
  110. Swarts, D. C., van der Oost, J. & Jinek, M. Structural basis for guide RNA processing and seed-dependent DNA targeting by CRISPR-Cas12a. Mol. Cell 66, 221–233 (2017). · DOI · Paper page
  111. Gao, P., Yang, H., Rajashankar, K. R., Huang, Z. & Patel, D. J. Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition. Cell Res. 26, 901–913 (2016). · DOI · Paper page
  112. Stella, S., Alcón, P. & Montoya, G. Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage. Nature 546, 559–563 (2017). · DOI · Paper page
  113. Cofsky, J. C. et al. CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks. eLife 9, e55143 (2020). · DOI
  114. Stella, S. et al. Conformational activation promotes CRISPR-Cas12a catalysis and resetting of the endonuclease activity. Cell 175, 1856–1871 (2018). This study provides extensive structural and mechanistic insights into the conformational activation of Cas12a. · DOI · Paper page
  115. Huang, X. et al. Structural basis for two metal-ion catalysis of DNA cleavage by Cas12i2. Nat. Commun. 11, 5241 (2020). · DOI
  116. Swarts, D. C. & Jinek, M. Mechanistic insights into the cis- and trans-acting DNase activities of Cas12a. Mol. Cell 73, 589–600 (2019). · DOI · Paper page
  117. Jiang, W. et al. CRISPR-Cas12a nucleases bind flexible DNA duplexes without RNA/DNA complementarity. ACS Omega 4, 17140–17147 (2019). · DOI
  118. Paul, B., Chaubet, L., Verver, D. E. & Montoya, G. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA. Nucleic Acids Res. https://doi.org/10.1093/nar/gkab1272 (2021). · DOI
  119. Losito, M., Smith, Q. M., Newton, M. D., Cuomo, M. E. & Rueda, D. S. Cas12a target search and cleavage on force-stretched DNA. Phys. Chem. Chem. Phys. 23, 26640–26644 (2021). · DOI
  120. Kapitonov, V. V., Makarova, K. S. & Koonin, E. V. ISC, a novel group of bacterial and archaeal DNA transposons that encode Cas9 homologs. J. Bacteriol. 198, 797–807 (2015). · DOI
  121. Shmakov, S. et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat. Rev. Microbiol. 15, 169–182 (2017). · DOI · Paper page
  122. Karvelis, T. et al. Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease. Nature 599, 692–696 (2021). · DOI · Paper page
  123. Weinberg, Z., Perreault, J., Meyer, M. M. & Breaker, R. R. Exceptional structured noncoding RNAs revealed by bacterial metagenome analysis. Nature 462, 656–659 (2009). · DOI
  124. Stoddard, B. L. Homing endonucleases from mobile group I introns: discovery to genome engineering. Mob. DNA 5, 7 (2014). · DOI · Paper page
  125. Stoddard, B. L. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 19, 7–15 (2011). · DOI · Paper page
  126. Klompe, S. E., Vo, P. L. H., Halpin-Healy, T. S. & Sternberg, S. H. Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration. Nature 571, 219–225 (2019). · DOI · Paper page
  127. Strecker, J. et al. RNA-guided DNA insertion with CRISPR-associated transposases. Science 365, 48–53 (2019). · DOI · Paper page
  128. Faure, G. et al. CRISPR–Cas in mobile genetic elements: counter-defence and beyond. Nat. Rev. Microbiol. 17, 513–525 (2019). · DOI · Paper page
  129. Peters, J. E., Makarova, K. S., Shmakov, S. & Koonin, E. V. Recruitment of CRISPR-Cas systems by Tn7-like transposons. Proc. Natl Acad. Sci. USA 114, E7358–E7366 (2017). · DOI · Paper page
  130. Rybarski, J. R., Hu, K., Hill, A. M., Wilke, C. O. & Finkelstein, I. J. Metagenomic discovery of CRISPR-associated transposons. Proc. Natl Acad. Sci. USA 118, e2112279118 (2021). · DOI
  131. Halpin-Healy, T. S., Klompe, S. E., Sternberg, S. H. & Fernández, I. S. Structural basis of DNA targeting by a transposon-encoded CRISPR-Cas system. Nature 577, 271–274 (2020). This work provides mechanistic insights into subtype I-F3 CRISPR transposases by describing the structures of a TniQ–Cascade complex and reveals interactions between TniQ and Cas6 and Cas7.1 within the Cascade complex. · DOI
  132. Li, Z., Zhang, H., Xiao, R. & Chang, L. Cryo-EM structure of a type I-F CRISPR RNA guided surveillance complex bound to transposition protein TniQ. Cell Res. 30, 179–181 (2020). · DOI
  133. Jia, N., Xie, W., de la Cruz, M. J., Eng, E. T. & Patel, D. J. Structure-function insights into the initial step of DNA integration by a CRISPR-Cas-Transposon complex. Cell Res. 30, 182–184 (2020). · DOI
  134. Wang, B., Xu, W. & Yang, H. Structural basis of a Tn7-like transposase recruitment and DNA loading to CRISPR-Cas surveillance complex. Cell Res. 30, 185–187 (2020). · DOI
  135. Park, J.-U. et al. Structural basis for target site selection in RNA-guided DNA transposition systems. Science 373, 768–774 (2021). This work provides mechanistic insights into subtype V-K CRISPR transposases by describing a transposition regulator, TnsC, from a subtype V-K CAST system and its interaction with TniQ and proposing a model for subtype V-K CAST transposition. · DOI
  136. Querques, I., Schmitz, M., Oberli, S., Chanez, C. & Jinek, M. Target site selection and remodelling by type V CRISPR-transposon systems. Nature 599, 497–502 (2021). This work provides mechanistic insights into subtype V-K CRISPR transposases by describing target recognition by Cas12k and the role of the transposition regulator TnsC and proposing an alternative model for subtype V-K CAST transposition. · DOI
  137. Xiao, R. et al. Structural basis of target DNA recognition by CRISPR-Cas12k for RNA-guided DNA transposition. Mol. Cell 81, 4457–4466.e5 (2021). · DOI
  138. Chowdhury, S. et al. Structure reveals mechanisms of viral suppressors that intercept a CRISPR RNA-guided surveillance complex. Cell 169, 47–57.e11 (2017). · DOI · Paper page
  139. Guo, T. W. et al. Cryo-EM structures reveal mechanism and inhibition of DNA targeting by a CRISPR-Cas surveillance complex. Cell 171, 414–426.e12 (2017). · DOI · Paper page
  140. Pausch, P. et al. Structural variation of type I-F CRISPR RNA guided DNA surveillance. Mol. Cell 67, 622–632.e4 (2017). · DOI
  141. Rollins, M. F. et al. Structure reveals a mechanism of CRISPR-RNA-guided nuclease recruitment and anti-CRISPR viral mimicry. Mol. Cell 74, 132–142.e5 (2019). · DOI
  142. Hayes, R. P. et al. Structural basis for promiscuous PAM recognition in type I–E Cascade from E. coli. Nature 530, 499–503 (2016). · DOI · Paper page
  143. Greene, E. C. & Mizuuchi, K. Dynamics of a protein polymer: the assembly and disassembly pathways of the MuB transposition target complex. EMBO J. 21, 1477–1486 (2002). · doi:10.1093/emboj/21.6.1477
  144. Vo, P. L. H. et al. CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering. Nat. Biotechnol. 39, 480–489 (2021). · DOI · Paper page
  145. Rubin, B. E. et al. Species- and site-specific genome editing in complex bacterial communities. Nat. Microbiol. 7, 34–47 (2021). · DOI · Paper page
  146. Stellwagen, A. E. & Craig, N. L. Avoiding self: two Tn7-encoded proteins mediate target immunity in Tn7 transposition. EMBO J. 16, 6823–6834 (1997). · DOI
  147. Saito, M. et al. Dual modes of CRISPR-associated transposon homing. Cell 184, 2441–2453 (2021). · DOI
  148. Petassi, M. T., Hsieh, S.-C. & Peters, J. E. Guide RNA categorization enables target site choice in Tn7-CRISPR-Cas transposons. Cell 183, 1757–1771.e18 (2020). · DOI
  149. Waddell, C. S. & Craig, N. L. Tn7 transposition: two transposition pathways directed by five Tn7-encoded genes. Genes Dev. 2, 137–149 (1988). · DOI
  150. Klompe, S. E. et al. Evolutionary and mechanistic diversity of type I-F CRISPR-associated transposons. Mol. Cell 82, 616–628 (2022). · DOI
  151. Liu, G., Lin, Q., Jin, S. & Gao, C. The CRISPR-Cas toolbox and gene editing technologies. Mol. Cell 82, 333–347 (2022). · DOI · Paper page
  152. Nambiar, T. S., Baudrier, L., Billon, P. & Ciccia, A. CRISPR-based genome editing through the lens of DNA repair. Mol. Cell 82, 348–388 (2022). · DOI · Paper page
  153. Lapinaite, A. et al. DNA capture by a CRISPR-Cas9 guided adenine base editor. Science 369, 566–571 (2022). · DOI · Paper page
  154. Chen, W. et al. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease. PLoS Biol. 17, e3000496 (2019). · DOI
  155. Guo, M. et al. Structural insights into a high fidelity variant of SpCas9. Cell Res. 29, 183–192 (2019). · DOI
  156. Shams, A. et al. Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules. Nat. Commun. 12, 5664 (2021). · DOI
  157. Donohoue, P. D. et al. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells. Mol. Cell 81, 3637–3649.e5 (2021). · DOI · Paper page
  158. Townshend, R. J. L. et al. Geometric deep learning of RNA structure. Science 373, 1047–1051 (2021). · DOI · Paper page
  159. Wei, J., Chen, S., Zong, L., Gao, X. & Li, Y. Protein-RNA interaction prediction with deep learning: structure matters. Preprint at arXiv https://arxiv.org/abs/2107.12243 (2021). · DOI
  160. Nierzwicki, Ł. & Palermo, G. Molecular dynamics to predict cryo-EM: capturing transitions and short-lived conformational states of biomolecules. Front. Mol. Biosci. 8, 641208 (2021). · DOI
  161. Wang, J. et al. Gaussian accelerated molecular dynamics: principles and applications. Wiley Interdiscip. Rev. Comput. Mol. Sci. 11, e1521 (2021). · DOI · Paper page
  162. Xiao, Y., Luo, M., Dolan, A. E., Liao, M. & Ke, A. Structure basis for RNA-guided DNA degradation by Cascade and Cas3. Science 361, eaat0839 (2018). · DOI

Cited by

See all 187

Metadata

Authors
Wang, J. Y., Pausch, P., & Doudna, J. A.
Venue
Nature Reviews Microbiology
Published
2022-05-13
Volume
20
Issue
11
Pages
641-656
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W4280501739
Cited by
187
References
19
FWCI
3.13
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural biology of CRISPR–Cas immunity and genome editing enzymes. https://app.cochat.ai/papers/10.1038/s41579-022-00739-4
The paper
Wang, J. Y., Pausch, P., & Doudna, J. A. (2022). Structural biology of CRISPR–Cas immunity and genome editing enzymes. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-022-00739-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.